Andera Partners
PARIS, null · Quarter end: Sep 30, 2026 · Filed with SEC: Oct 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$175.7M2026 Q3
Positions7
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%
Top Holdings
KMTS
Kestra Medical Technologies
43.9%
MLYS
Mineralys Therapeutics
22.8%
AVLN
Avalyn Pharma
15.1%
AGMB
AgomAb Therapeutics
9.7%
IVA
Inventiva S.A.
7.6%
EVMN
Evommune
0.5%
NYXH
Nyxoah
0.4%
New / Increased
0 new · 0 increased
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.